ArticleCancer management and research2022

Recombinant Oncolytic Adenovirus Combined with Cyclophosphamide Induces Synergy in the Treatment of Breast Cancer in vitro and in vivo.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.